Aspire Biopharma Inc. (ASBPW)
NasdaqCM: ASBPW
· Echtzeitkurs · USD
0.02
+0.00 (0.00%)
Zum Schluss: Aug 13, 2026, 3:41 PM
Aspire Biopharma Inc. (ASBPW) Stock Price, Analysis & Data
0.00% (1D)
| Geld | 0.02 |
| Marktkapitalisierung | n/a |
| Umsatz (TTM) | 34.55K |
| Nettogewinn (TTM) | -11.76 Mio |
| Beta | 0.11 |
| EPS (ttm) | n/a |
| KGV (TTM) | n/a |
| Forward-KGV | n/a |
| KBV (TTM) | n/a |
| KUV (TTM) | n/a |
| Earnings Date | n/a |
| Brief | n/a |
| Volumen | 8,286 |
| Ø Vol. (20D) | |
| Eröffnung | 0.04 |
| Vortagesschluss | 0.02 |
| Tagesspanne | 0.02 - 0.02 |
| 52-Wk Range | 0.02 - 0.02 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über ASBPW
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid prod...
IPO Datum Jul 17, 2026
Mitarbeiter n/a
Börse NasdaqCM
Tickersymbol ASBPW
Website https://aspirebiolabs.com
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von Aspire Biopharma 6.2K, ein Anstieg von undefined% im Vergleich zum Vorjahr (0). Der Gewinn lag bei -24.48 Mio, ein Anstieg von 1,768.95 %.
Finanzberichte
vor 9 Monaten · Associated Press Finance
BC-Most Active StocksEPWK Holdings Ltd. 243,983,973 0.0655